Tumor endothelial cell—a biological tool for translational cancer research

Dorcas Akuba Muhyia Annan, Hiroshi Kikuchi, Nako Maishi, Yasuhiro Hida, Kyoko Hida

Research output: Contribution to journalReview articlepeer-review

19 Citations (Scopus)


Going from bench to bedside is a simplified description of translational research, with the ultimate goal being to improve the health status of mankind. Tumor endothelial cells (TECs) perform angiogenesis to support the growth, establishment, and dissemination of tumors to distant organs. TECs have various features that distinguish them from normal endothelial cells, which include alterations in gene expression patterns, higher angiogenic and metabolic activities, and drug resistance tendencies. The special characteristics of TECs enhance the vulnerability of tumor blood vessels toward antiangiogenic therapeutic strategies. Therefore, apart from being a viable therapeutic target, TECs would act as a better mediator between the bench (i.e., angiogenesis research) and the bedside (i.e., clinical application of drugs discovered through research). Exploitation of TEC characteristics could reveal unidentified strategies of enhancing and monitoring antiangiogenic therapy in the treatment of cancer, which are discussed in this review.

Original languageEnglish
Article number3238
JournalInternational journal of molecular sciences
Issue number9
Publication statusPublished - 01-05-2020
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Catalysis
  • Molecular Biology
  • Spectroscopy
  • Computer Science Applications
  • Physical and Theoretical Chemistry
  • Organic Chemistry
  • Inorganic Chemistry


Dive into the research topics of 'Tumor endothelial cell—a biological tool for translational cancer research'. Together they form a unique fingerprint.

Cite this